These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3951807)

  • 1. A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas.
    Palmer DJ; Goldberg MF; Frenkel M; Fiscella R; Anderson RJ
    Ophthalmology; 1986 Jan; 93(1):102-8. PubMed ID: 3951807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema.
    McGetrick JJ; Jampol LM; Goldberg MF; Frenkel M; Fiscella RG
    Arch Ophthalmol; 1983 Jul; 101(7):1031-3. PubMed ID: 6870623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid.
    Kraft SP; Christianson MD; Crawford JS; Wagman RD; Antoszyk JH
    Ophthalmology; 1987 Oct; 94(10):1232-7. PubMed ID: 3317180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
    Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
    Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
    Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of traumatic hyphema with topical epsilon-aminocaproic acid.
    Goldberg MF
    Arch Ophthalmol; 1997 Sep; 115(9):1189-90. PubMed ID: 9298063
    [No Abstract]   [Full Text] [Related]  

  • 7. The incidence of rebleeding in traumatic hyphema.
    Witteman GJ; Brubaker SJ; Johnson M; Marks RG
    Ann Ophthalmol; 1985 Sep; 17(9):525-6, 528-9. PubMed ID: 4062157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model.
    Allingham RR; Crouch ER; Williams PB; Catlin JC; Loewy DM; Jacobson J
    Arch Ophthalmol; 1988 Oct; 106(10):1436-8. PubMed ID: 3178555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema.
    Dieste MC; Hersh PS; Kylstra JA; Larrison WI; Frambach DA; Shingleton BJ
    Am J Ophthalmol; 1988 Oct; 106(4):383-90. PubMed ID: 3177553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial.
    Farber MD; Fiscella R; Goldberg MF
    Ophthalmology; 1991 Mar; 98(3):279-86. PubMed ID: 2023746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure increase associated with traumatic epsilon-aminocaproic acid therapy for traumatic hyphema.
    Romano PE
    Am J Ophthalmol; 1989 May; 107(5):568-70. PubMed ID: 2712150
    [No Abstract]   [Full Text] [Related]  

  • 12. Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema.
    Kutner B; Fourman S; Brein K; Hobson S; Mrvos D; Sheppard J; Weisman S
    Arch Ophthalmol; 1987 Feb; 105(2):206-8. PubMed ID: 3813951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is topical corticosteroid necessary in traumatic hyphema?
    Türkoğlu EB; Celik T; Celik E; Ozkan N; Bursalı O; Coşkun SB; Alagoz G
    J Fr Ophtalmol; 2014 Oct; 37(8):613-7. PubMed ID: 25199483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
    Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
    Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
    Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
    Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent bleeding following traumatic hyphema due to mild hemophilia B (Christmas disease).
    Wilker SC; Singh A; Ellis FJ
    J AAPOS; 2007 Dec; 11(6):622-3. PubMed ID: 17720569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema.
    Nasrullah A; Kerr NC
    Am J Ophthalmol; 1997 Jun; 123(6):783-90. PubMed ID: 9535622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and recurrent hyphema after blunt ocular trauma.
    Ganley JP; Geiger JM; Clement JR; Rigby PG; Levy GJ
    Am J Ophthalmol; 1983 Dec; 96(6):797-801. PubMed ID: 6660269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Frenkel M
    Am J Ophthalmol; 1976 Mar; 81(3):355-60. PubMed ID: 769560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.